"I was screaming hallelujah": Patient and provider perceptions of blood-based testing for colorectal cancer screening

PLoS One. 2023 Dec 21;18(12):e0295685. doi: 10.1371/journal.pone.0295685. eCollection 2023.

Abstract

Background: Blood-based tests for colorectal cancer (CRC) screening can offer many advantages over stool-based tests such as FIT. Yet, we know little about patients' and providers' perceptions of this type of test. We report findings from a qualitative study comparing patient and provider perceptions of blood-based testing for CRC screening.

Methods: Patient participants were aged 45-75 years and members of a large, integrated health system. Participants were mailed, but did not complete, a FIT through an organized FIT-screening program and were scheduled for a health-care encounter at any of nine clinical sites. Participants were consented to complete a blood draw. We used purposive sampling to select and recruit patients (who did and did not complete the blood test) and providers/specialists who would be involved in offering the blood test to patients or explaining results. We administered telephone interviews using a semi-structured interview guide and recorded and transcribed all interviews, then coded and analyzed content.

Results: We interviewed 15 patients (11 completed and 4 did not complete the blood test) and 5 providers (3 primary care providers, one gastroenterologist (GI), and one GI medical assistant). Patients were enthusiastic about completing a blood test, citing the simplicity, ease, convenience, and high perceived accuracy of the test. Providers were also receptive to a blood-based option, if adequate test performance could be achieved and if they have information that informs patients about the pros and cons of blood-based screening versus other screening tests.

Conclusions: Patients and providers were willing and enthusiastic about blood-based CRC screening tests. Future research focusing on performance and communication is needed.

MeSH terms

  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / prevention & control
  • Communication
  • Early Detection of Cancer* / methods
  • Hematologic Tests
  • Humans
  • Mass Screening / methods
  • Occult Blood
  • Qualitative Research

Grants and funding

This study was funded by Guardant Health (Home - GuardantHealth) through a contract to the Kaiser Permanente Center for Health Research. The funders processed blood samples for the study, but otherwise had no role in the study design, data collection, decision to publish or preparation of the manuscript.